compounds and pharmaceutical compositions comprising compounds of the formula as cb 1 receptor inverse agonists useful for reducing body weight in mammals , treating cognitive impairment associated with schizophrenia , and mitigating treatment emergent weight gain observed during treatment with antipsychotics .